» Articles » PMID: 35509317

Improving the Yield and Quality of Daptomycin in by Multilevel Metabolic Engineering

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 May 5
PMID 35509317
Authors
Affiliations
Soon will be listed here.
Abstract

Daptomycin is a cyclic lipopeptide antibiotic with a significant antibacterial action against antibiotic-resistant Gram-positive bacteria. Despite numerous attempts to enhance daptomycin yield throughout the years, the production remains unsatisfactory. This study reports the application of multilevel metabolic engineering strategies in to reconstruct high-quality daptomycin overproducing strain L2797-VHb, including precursor engineering (i.e., refactoring kynurenine pathway), regulatory pathway reconstruction (i.e., knocking out negative regulatory genes and ), byproduct engineering (i.e., removing pigment), multicopy biosynthetic gene cluster (BGC), and fermentation process engineering (i.e., enhancing O supply). The daptomycin titer of L2797-VHb arrived at 113 mg/l with 565% higher comparing the starting strain L2790 (17 mg/l) in shake flasks and was further increased to 786 mg/l in 15 L fermenter. This multilevel metabolic engineering method not only effectively increases daptomycin production, but can also be applied to enhance antibiotic production in other industrial strains.

Citing Articles

Overproduction of endusamycin in subsp. .

Chang Y, Liu Z, Deng Z, Liu T Synth Syst Biotechnol. 2025; 10(2):523-531.

PMID: 40061181 PMC: 11889735. DOI: 10.1016/j.synbio.2025.02.004.


The Transcriptional Regulator DhyR Positively Modulates Daptomycin Biosynthesis in Streptomyces roseosporus.

He F, Liu X, Wang H, Li X, Wu Y, Zhang D Microb Biotechnol. 2025; 18(3):e70110.

PMID: 40025688 PMC: 11872808. DOI: 10.1111/1751-7915.70110.


Metabolic engineering of for high-level production of pneumocandin B.

Zhang X, Cheng S, Yang J, Lu L, Deng Z, Bian G Synth Syst Biotechnol. 2025; 10(2):381-390.

PMID: 39830076 PMC: 11742615. DOI: 10.1016/j.synbio.2024.12.008.


Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin.

Li X, Sang Z, Zhao X, Wen Y Microb Biotechnol. 2024; 17(11):e70038.

PMID: 39487765 PMC: 11530997. DOI: 10.1111/1751-7915.70038.


Stepwise increase of fidaxomicin in an engineered heterologous host through multi-level metabolic engineering.

Xie H, Su Y, Bu Q, Li Y, Zhao Q, Du Y Synth Syst Biotechnol. 2024; 9(4):766-774.

PMID: 39021363 PMC: 11253128. DOI: 10.1016/j.synbio.2024.06.004.


References
1.
Wentzel A, Bruheim P, Overby A, Jakobsen O, Sletta H, Omara W . Optimized submerged batch fermentation strategy for systems scale studies of metabolic switching in Streptomyces coelicolor A3(2). BMC Syst Biol. 2012; 6:59. PMC: 3431225. DOI: 10.1186/1752-0509-6-59. View

2.
Mironczuk A, Kosiorowska K, Biegalska A, Rakicka-Pustulka M, Szczepanczyk M, Dobrowolski A . Heterologous overexpression of bacterial hemoglobin VHb improves erythritol biosynthesis by yeast Yarrowia lipolytica. Microb Cell Fact. 2019; 18(1):176. PMC: 6794898. DOI: 10.1186/s12934-019-1231-9. View

3.
Murakami T, Burian J, Yanai K, Bibb M, Thompson C . A system for the targeted amplification of bacterial gene clusters multiplies antibiotic yield in Streptomyces coelicolor. Proc Natl Acad Sci U S A. 2011; 108(38):16020-5. PMC: 3179087. DOI: 10.1073/pnas.1108124108. View

4.
Staunton J, Weissman K . Polyketide biosynthesis: a millennium review. Nat Prod Rep. 2001; 18(4):380-416. DOI: 10.1039/a909079g. View

5.
Miao V, Coeffet-LeGal M, Brian P, Brost R, Penn J, Whiting A . Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology (Reading). 2005; 151(Pt 5):1507-1523. DOI: 10.1099/mic.0.27757-0. View